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1. Introduction 
Formation of the peptide bond in the elongation 
cycle is accompanied by cleavage of GTP in a ternary 
complex aminoacyl-tRNA-GTP-EF-Tu and by the 
liberation of EF-Tu-GDP t Pi from the ribosome. 
If the cleavage is prevented by replacing GTP with 
its non-cleavable analogue GMPPCP*, no peptide bond 
is formed in spite of the fact that the ternary complex 
which remains bound to the ribosome by a coded 
link, contains aminoacyl-tRNA [l-3] . The presence 
of EF-Tu on the ribosome is considered to be inhibi- 
tory [3,4]. Evidence is presented here that no peptide 
bond can be formed because the o-amino group of 
aminoacyl-tRNA is protected from acylation as long as 
it is bound in the complex aminoacyl-tRNA-GTP- 
EF-Tu. Specific chemical acylation of free and of 
EF-Tu-complexed aminoacyl-tRNA served as a 
model system. 
2. Materials and methods 
The N-hydroxysuccinimide ester of acetic acid 
was prepared according to [5] . [ 3H] Phenylalanyl- 
tRNA containing 140 pmol phenylalanine per mg 
was prepared by charging total transfer RNA of 
Escherichia coli with [3H] phenylalanine of specific 
activity 165 Ci/mmol (Amersham, England). The 
EF-Tu elongation factor was prepared in the crystalline 
form as EF-Tu-GDP according to [6] . GTP, phos- 
%MPPCP: 5’-guanylyl methylene diphosphonate. 
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phoenolpyruvate, phosphoenolpyruvate kinase were 
from Calbiochem (Switzerland), GMPPCP from P-L 
Biochemicals (USA), all the other chemicals were 
from Lachema (Czechoslovakia). 
Time course of acylation: The reaction mixtures 
of 0.75 ml volume had the following final com- 
position: 100 mM Tris-acetate (pH 7.6) 100 mM 
ammonium chloride, 10 mM magnesium acetate, 
15 mM mercaptoethanol, 63 mM N-hydroxy- 
succinimide ester of acetic acid and 106 pg [3H] 
phenylalanyl-tRNA. The complexes were formed by 
preincubations in mixtures of the same ionic compo- 
sition as that of the reaction mixture. The complex of 
Phe-tRNA-GTP-EF-Tu was formed in a volume of 
0.2 ml by preincubation of 40 pg EF-Tu-GDP with 
1 pmol GTP, 75 pmol phosphoenolpyruvate and 
30 pg pyruvate kinase for 10 min at 35°C and by 
subsequent preincubation at 0°C for 1 min with 
100 pg Phe-tRNA. The complex of Phe-tRNA- 
GMPPCP-EF-Tu was formed in a volume of 0.2 ml 
by preincubation of 40 c(g EF-Tu-GDP, 10 pg EF-Tu- 
EF-Ts and 10 pmol GMPPCP for 10 min at 35”C, and 
by subsequent preincubation at 0°C for 1 min with 
100 ,ug Phe-tRNA. The acylation reaction was started 
by adding a solution of N-hydroxysuccinimide ester 
of acetic acid and was carried out at 0°C. Samples 
(0.1 ml) were removed from the reaction mixture at 
the times shown and combined with 0.1 ml solution 
of 100 mM glycine and 100 mM NaCl containing 
100 pg carrier RNA and 1 ml cold 5% trichloracetic 
acid. The precipitates were centrifuged and the 
sediment was hydrolysed with 0.6 ml 100 mM NaOH 
for 30 min at 40°C. The samples were acidified with 
0.1 ml 10 M hydrochloric acid and extracted with 1 ml 
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ethyl acetate. The radioactivity of the dried organic 
phase representing the amount of acylated phenyl- 
alanyl-tRNA [see 71 was counted in a gas-flow 
counter. 
3. Results 
The rate of acylation of aminoacyl-tRNA both free 
and bound in a complex with the elongation factor 
was studied. The a-amino group of phenylalanyl-tRNA 
was chemically acetylated by the N-hydroxysuccini- 
mide ester of acetic acid. The time course of the 
acetylation reaction in the presence of a large excess of 
the reagent and at neutral pH is shown in fig.1. 
Acetylation follows first-order kinetics. With free 
phenylalanyl-tRNA the half time of the acetylation 
reaction is about 30 sec. Acetylation of phenylalanyl- 
tRNA bound in complex of Phe-tRNA-GTP-EF-Tu 
proceeds at a 70 times slower rate, acetylation of 
phenylalanyl-tRNA in the complex with the non- 
cleavable analogue GMPPCP is about 40 times slower. 
The individual components of the acetylation mix- 
ture have no substantial effect on the decrease of the 
reaction rate under conditions when complexes of the 
factor with aminoacyl-tRNA are not formed - no 
appreciable decrease is caused by EF-Tu-GDP or by 
GMPPCP or by phosphoenolpyruvate and pyruvate 
kinase. 
The fact that the rate of acylation, though very low, 
is still detectable may be accounted for by the high but 
finite stability constant of the complexes. The relative 
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Fig.1. Acetylation of free and EF-Tu-complexed phenyl- 
alanine-tRNA. 
difference in the rate of acylation between the com- 
plexes with GTP and with GMPPCP may reflect the 
difference in these stability constants. 
4. Discussion 
During the biosynthesis of proteins a new peptide 
bond is formed in analogy to the process studied in 
the model of acetylation of aminoacyl-tRNA with 
N-hydroxyccuccimnimide ester. The acylating agent 
is a peptide linked through an activated ester bond in 
peptidyl-tRNA. According to our experiments the 
ternary complex protects aminoacyl-tRNA from 
acylation so that it is not accesible even for the 
sterically non-demanding acetyl group. The ternary 
complex is rather stable so that one may assume that 
its components remain bound in the same way even 
on the ribosome provided the GTP was not yet split 
or the analogue used could not be split. The assump- 
tion is justified that the EF-Tu factor protects 
aminoacyl-tRNA in the ribosome from acylation by 
the growing peptide for the period during which the 
recognition is not yet concluded and the correct 
aminoacyl-tRNA has not yet been selected by the 
codon-anticodon checking process. As soon as the 
correct aminoacyl-tRNA is selected, GTP is split, the 
factor EF-Tu is liberated from the complex and the 
a-amino group is exposed for subsequent acylation 
with a peptide. 
Apparently the EF-TU factor plays a key role 
in the error-free decoding process during peptide 
elongation. Already at the stage of complex forma- 
tion the ternary complex is formed only with amino- 
acyl-tRNA, discriminating thus against the incorrect 
derivatives to tRNA [see e.g. 81 that might stop the 
translation process on the ribosome. It enhances the 
interaction of correct aminoacyl-tRNA with the 
ribosome under rearrangement of the tertiary structure 
of aminoacyl-tRNA which permits the participation of 
another binding site on the 30 S subunit [9]. The 
present evidence that the a-amino group of aminoacyl- 
tRNA is protected from acylation in a complex of 
aminoacyl-tRNA-GTP-EF-Tu makes it possible to 
envisage another function of the EF-Tu factor, 
namely to prevent the formation of a peptide bond, 
unless the selection of the correct aminoacyl-tRNA 
has been properly completed. 
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